304 studies found for:    Shingles
Show Display Options
Rank Status Study
1 Recruiting Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds
Conditions: Adult;   Shingles;   Herpes Zoster
Interventions: Biological: Zostavax;   Biological: HZ/su vaccine;   Biological: Placebo
2 Completed A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
Conditions: Herpes Zoster;   Shingles
Interventions: Drug: valacyclovir;   Drug: FV-100;   Drug: Valacyclovir placebo;   Drug: FV-100 placebo
3 Active, not recruiting ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)
Conditions: Herpes Zoster;   Shingles
Intervention: Biological: ZOSTAVAX™
4 Completed Shingles Prevention Study
Conditions: Herpes Zoster;   Postherpetic Neuralgia
Interventions: Biological: Varicella-zoster vaccine;   Biological: Placebo
5 Active, not recruiting Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A;   Biological: Placebo
6 Completed
Has Results
A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)
Condition: Herpes Zoster
Interventions: Biological: zoster vaccine live (ZOSTAVAX™);   Biological: Comparator: Placebo
7 Completed Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates
Condition: Herpes Zoster Disease
Intervention: Other: An informational packet regarding shingles and the HZV was sent to patients identified by the EMR
8 Completed Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects
Conditions: Herpes Zoster (Shingles);   Shingles
Interventions: Biological: Herpes Zoster vaccine GSK1437173A;   Biological: Placebo
9 Active, not recruiting
Has Results
Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)
Condition: Herpes Zoster
Intervention: Biological: Zoster Vaccine, Live
10 Completed Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and Elderly
Condition: Shingles
Intervention: Biological: ZOSTAVAX
11 Completed
Has Results
A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)
Condition: Herpes Zoster
Interventions: Biological: Comparator: zoster vaccine live (Oka/Merck) refrigerated formulation;   Biological: Comparator: zoster vaccine live (Oka/Merck) frozen formulation
12 Completed Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Conditions: Herpes Zoster;   Herpes Zoster Vaccine
Interventions: Biological: Herpes zoster vaccine GSK1437173A;   Biological: Placebo
13 Active, not recruiting Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster vaccine (GSK1437173A)
14 Completed VZV PCR Sampling Validation Study
Condition: Herpes Zoster
Interventions: Procedure: Herpes zoster sampling procedure for VZV PCR;   Procedure: Blood sampling
15 Completed Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A
Condition: Herpes Zoster in Autologous Hematopoietic Stem Cell Transplantation Recipients
Interventions: Biological: Herpes Zoster Vaccine 1437173A;   Biological: Placebo vaccine (saline)
16 Active, not recruiting T Cell Responses to Varicella Zoster Virus (VZV)
Condition: Immune Response to Zoster Vaccine
Intervention: Biological: Zostavax™
17 Completed Shingles: Immune Effects of Tai Chi
Conditions: Aging;   Herpes Zoster
Intervention: Behavioral: Tai Chi Chih
18 Completed Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)
Condition: Shingles
Interventions: Biological: zoster vaccine live (Oka/Merck);   Biological: Comparator: placebo (unspecified)
19 Completed
Has Results
Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)
Condition: Shingles
Interventions: Biological: Zoster Vaccine, Live (Zostavax™);   Biological: Comparator: Placebo
20 Recruiting Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents
Conditions: Immunosenescence;   Shingles
Intervention: Biological: Varicella Zoster Virus Vaccine (Zostavax)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years